Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
We’ve all heard that Shockwave IVL doesn’t work in eccentric calcium… well that’s just a myth. Watch Prof. Andrew Holden’s presentation from CIRSE21 as he walks you through IVL’s eccentric vs concentric lesion data subset from the PADIII Observational Study and learn how this myth can well and truly be dispelled.
Topics: Peripheral IVL, Peripheral Conferences, Peripheral Clinical Data, Treating Different Ca++ Morphologies
In anticipation of TCT starting in early November, we had quick conversation with Shockwave Medical’s Chief Medical Officer, Dr. Keith Dawkins, about IVL’s presence at the meeting and the most interesting data coming out. Hope you enjoy his perspective!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, SWAV News, ChalkTalk Podcast
Explore the new world of Shockwave with Paul Higginbottom, Director of Sales in the UK and France, in ChalkTalk episode five. With over 10+ years in the medical device industry and a complex PCI background, Paul recounts the joys of his career journey but explains how the unique attributes of IVL and start-up environment are what compelled him to join Shockwave at the beginning of this year. He provides insights into Shockwave’s culture, shares challenges that he has faced already, and talks about going direct in the UK and France. Listen to catch Paul’s first interactions with physicians and their surprising feedback – enjoy!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, SWAV News, ChalkTalk Podcast
This year at TCT 2021, we’re pulling out all the stops. With inpatient and outpatient reimbursement now in place, we’ve delved deeper into the current coronary IVL clinical evidence to get data-driven answers for some of your most pressing questions:
Topics: Coronary IVL
Dr. Ehrin Armstrong presented the interim results from the first 752 patients in the Disrupt PAD III Observational Study (OS), reinforcing the consistency of IVL's unique mechanism of action to safely and effectively modify superficial and deep calcium across multiple vessel beds, lesion types and CLI patients.
Topics: Peripheral IVL, Peripheral Conferences, Peripheral Clinical Data
Eccentric calcium has challenged current modalities’ ability to adequately modify calcium due to several device-dependent factors. NC balloons often expand the healthy, non-calcified side of the artery, while high pressure or cutting balloons may result in disruption or dissection of healthy intima. Even atherectomy devices are limited due to wire bias that may often result in nonuniform ablation of calcium leaving the calcified plaque untouched.
Topics: Coronary IVL, Shockwave C2, Treating Different Ca++ Morphologies
Dr. Evan Shlofmitz, DO, Director of Intravascular Imaging, St. Francis Hospital - The Heart Center, Roslyn, New York shares with us his extensive experience with imaging modalities and how the use of intravascular imaging helped create treatment algorithms at St. Francis Hospital to decide on the appropriate calcium modification tool. He also speaks about his experience with Coronary IVL, its safety and the use of OCT to enhance our ability to use intravascular lithotripsy, including case selection and ensuring adequate outcomes.
Topics: Coronary IVL, Shockwave C2, Calcium Corner
If you are attending VIVA21, you may not be dealing cards, but you’re likely dealing with peripheral artery calcium. So join Dr. Sahil Parikh, Dr. Ehrin Armstrong, Dr. Venita Chandra and Dr. Peter Soukas at 12pm Pacific Time on Wednesday, October 6th in the Bandol Room to make sure you don’t gamble with your calcium strategy. Listen to the esteemed panel during the Shockwave Medical Symposium and you learn how Intravascular Lithotripsy (IVL) can help you beat the odds.
Topics: Peripheral IVL, Peripheral Conferences, Peripheral Clinical Data
Follow the journey of Prof. James Spratt, a specialist in complex PCI and education, as he moves from early IVL adopter to expert in the technology. ChalkTalk episode four captures how Prof. Spratt, from St. George’s Hospital, University of London, first discovered Shockwave and why he now believes the technology is disruptive in the calcium space. Spratt describes how focusing on Optima education and practicing interventional cardiology helped get him to where he is today. Being an expert in the field, Spratt recognized the need for simplifying calcium education, which became the foundation that Shockwave and Optima's Calcium Masterclass was built upon. Hear more from Prof. James Spratt by tuning into the remaining Calcium Masterclasses!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, SWAV News, ChalkTalk Podcast
Want to learn about Coronary IVL and get CME credits? You're in luck! SCAI is offering a great recorded case and discussion for 1.5 credits featuring an all-star panel of Shockwave IVL experts.
Topics: Coronary IVL
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
